DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M.
Benfotiamine blocks three major pathways of hyperglycaemic damage and prevents experimental diabetic retinopathy.
Nature Medicine 2003; 9 ((3)) 294-299
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.